Luteal phase support in in-vitro fertilization

Middle East Fertility Society Journal

Volumn 11, Issue 1, 2006, Pages 64-69

  Al Inizi, Shamma Thwaini ^a,b   Asaad, Magdy ^a   Schick, Juergen ^a  

^a TAWAM HOSPITAL   (United Arab Emirates)

^b Moor House   (United Kingdom)

Author keywords

Clinical pregnancy rate; Luteal phase support

Indexed keywords

CHORIONIC GONADOTROPIN; DYDROGESTERONE; GONADORELIN AGONIST; PROGESTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG USE; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; INTERMETHOD COMPARISON; LUTEAL PHASE; MAJOR CLINICAL STUDY; PREGNANCY RATE; PREGNANCY TEST; RETROSPECTIVE STUDY; STUDENT T TEST; TERTIARY HEALTH CARE; TREATMENT OUTCOME; UNITED ARAB EMIRATES;

EID: 33744905806     PISSN: 11105690     EISSN: 11105690     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Daya S. Ovulation induction for corpus luteum deficiency. Semin Reprod Endocrinol, 1990; 8: 156-65.
2. Van der Wiele RL, Bagumil J, Dyrenfurth I, Ferin M, Jewelewicz R, Warren M et al. Mechanisms regulating the menstrual cycles in women. Recent progress in hormone research.1970; 26:63-103.
3. Daya S, Gunby J. Luteal phase support in assisted reproductive cycles. (Cochrane review) In: The Cochrane library, Issue 3, 2004, chichester, UK: John Wiley and Sons Ltd.
4. Damario MA, Goudas VT, Session DR., Hammitt DG, Dumesic DA. Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization- embryo transfer. Fertil Steril. 1999; 72 (5), 829-836.
5. Friedler S, Raziel A, Schachter M. Luteal support with micronized progesterone following in vitro fertilization using a down regulation protocol with gonadotropin releasing hormone agonist: a comparative study between vaginal and oral administration. Hum Reprod 1999; 14 (8), 1944-1948.
6. Martinez F, Coroleu B, Parera N. Human chorionic gonadotropin and intra-vaginal natural progesterone are equally effective for luteal phase support in IVF. Gynecol Endorinol. 2000; 14(5): 316-320.
7. Soliman S, Daya S, Collins J. The role of luteal phase support in infertility treatment: a meta analysis of randomized trials. Fertil Steril. 1994; 61, 1068-1076.
8. Palermo GD, Cohen J, Alikani M. Intra-cytoplasmic sperm injection: a novel treatment for all forms of male factor infertility. Fertil Steril., 1995; 63: 1231-1240.
9. Smith J, O skeowitz G, Tayi R. Abbott Ax SYM. Random and continuous access immunoassay system for improved workflow in the clinical laboratory. Clin Chem, 1993; 39: 2063-2069.
10. Smitz J, Devroey P, Camus M. The luteal phase and early pregnancy after combined Gonadotropin releasing hormone analogue/ human menopausal gonadotropin treatment for super ovulation in in-vitro fertilization or gamete intra-fallopian transfer. Hum Reprod 1988; 3: 585-590.
11. Smith EM, Anthony FW, Gadd SC. Trial of support treatment with human chorionic gonadotropin in luteal phase after treatment with buserelin and human menopausal gonadotropin in women taking part in an in-vitro fertilization program. Br Med J. 1989; 298: 1483-1486.
12. Herman A, Ron EL R, Golan A. Pregnancy rate and ovarian hyper-stimulation after luteal human chorionic gonadotropin releasing hormone analogue and menotrophins. Fertil Steril. 1990; 53: 92-96.
13. Gersak K, Tomazevic T. Sub populations of human granulosa-luteal cells obtained from gonadotropin or gonadotropin releasing hormone agonist/ gonadotropin treated follicles in in vitro fertilization-embryo transfer cycles. J Assist Reprod Genet. 1999; 16 (9): 488-491.
14. Beckers NG, Macklon NS, Eijkemans MJ, Ludwig M, Felberbaun RE, Diedrich K et al. Non supplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin - releasing hormone agonist to induce final oocyte maturation in in- vitro fertilization patients after ovarian stimulation with recombinant FSH and GnRh a co treatment. J Clin Endocrinol Metab. 2003; 88(9):4186-4192.
15. Abate A, Brigandi A, Abate FG, Manti F, Unfer V, Perino M. Luteal phase support with 17 alpha hydroxy progesterone versus unsupported cycles in in- vitro fertilization: a comparative randomized study. Gynecol Obstet Invest., 1999;48(2): 78-80.
16. Abate A, Perino M, Abate FG, Brigandi A, Costabile L, Manti F. Intramuscular versus vaginal administration of progesterone for luteal phase support after IVF-ET . A comparative randomized study. Clin Exp Obstet Gynecol. 1999; 26: 203-206.
17. Tavaniotou A, Smilz J, Bourgain C, Devroey P. Comparison between different routes of progesterone administration as luteal phase support in infertility treatment. Hum Reprod Update. 2000;6(2): 139-148.
18. Penzias As. Luteal phase support. Fertil Steril. 2002, 77(2): 318-323.
19. Anserini P, Costa M, Remorgida V, Sarli R, Guglielminetti E, Ragni N. Luteal phase support in assisted reproductive cycles using either vaginal (crinone 8%) or intramuscular (prontogest) progesterone: results of a prospective randomized study. Minerva Ginecol. 2001; 53(4): 297-301.
20. Dunstone T, Zosmer A, Hussain S, Tozer A, Paney N, Wilson C et al. A comparison between cyclogest pessaries and crinone gel as luteal support in IVF-ET cycles. British Fertility Society Annual meeting abstract book. 1999; 62 (Abstract# Fc21).
21. Ludwig M, Schwartz P, Babahan A, Weiss JM, Felberbaum R et al. Luteal phase support using either crinone 8% or uterogest : results of a prospective randomized study. Europ J obstet gynaecol. 2002; 103: 48-52.
22. Buvat J, Marcolin G, Guittard C. Luteal support after luteinizing hormone releasing hormone agonist for in-vitro fertilization: superiority of human gonadotropin over oral progesterone. Fertil Steril.1990; 53: 490-494.
23. Fanchin R, De Ziegler D, Bergeron C. Trans-vaginal administration of progesterone: dose response data support a first uterine pass effect. Obstet Gynecol. 1997; 90:396-401.
24. Pouly JL, Bassil S, Frydman R. Luteal support after in-vitro fertilization: crinone 8%, a sustained release vaginal progesterone gel, versus Uterogestan, an oral micronized progesterone. Hum Reprod. 1996; 11: 2085-2089.
25. Norman TR, Morse CA, Dennerstein L. Comparative bioavailability of orally and vaginally administered progesterone. Fertil Steril. 1991; 56(6):1034-1039.
26. De Ziegler D. Hormonal control of endometrial receptivity. Hum Reprod. 1995; 10: 4-7.
27. De Ziegler D, Bouchard P. Understanding endometrial physiology and menstrual disorders in the 1990's. Curr Opin Obstet Gynecol. 1993; 5: 378-388.
28. Fujimoto A, O suga Y, Fujiwara T, Yano T, Tsutsumi O, Momoeda M et al. hCG combined with progesterone for luteal support improves pregnancy rate in patients with low late mid luteal estradiol levels in IVF cycles. J Assist Reprod Genet. 2002, 19(12): 550-554.
29. Farhi J, Weissman A, Steinfeld Z, Shorer M, Nahum H, Levran D. Estradiol supplementation during luteal phase may improve the pregnancy rate in patients undergoing IVF-ET cycles. Fertil Steril. 2000; 73(4): 761-766.
30. Pritts EA, Atwood AK. Luteal phase support in infertility treatment: a meta- analysis of the randomized trials. Hum Reprod.2002; 17(9): 2287-2299.
31. Nosarka S, Kruger T, Siebert I, Grové D. Luteal Phase Support in in vitro Fertilization: Meta-Analysis of Randomized Trials. Gyn Obstet Invest. 2005;23,60(2):67-74.